Search

Displaying results 7071 - 7080 of 8573 in total
  1. Drug

    Levosemotiadil

    go.drugbank.com/drugs/DB20446
    Experimental

    Levosemotiadil has a monoisotopic molecular weight of 536.2 Da.

  2. Drug

    Ipramidil

    go.drugbank.com/drugs/DB20454
    Experimental

    Ipramidil has a monoisotopic molecular weight of 256.12 Da.

  3. Drug

    Norgesterone

    go.drugbank.com/drugs/DB21409
    Experimental

    Norgesterone has a monoisotopic molecular weight of 300.21 Da.

  4. Drug

    Pitenodil

    go.drugbank.com/drugs/DB21442
    Experimental

    Pitenodil has a monoisotopic molecular weight of 353.18 Da.

  5. Drug

    Iopentol

    go.drugbank.com/drugs/DB13861
    Experimental

    Iopentol is used as a contrast medium.

  6. Drug

    MLN3897

    go.drugbank.com/drugs/DB06505
    Experimental

    MLN3897, a novel CCR1 inhibitor, disrupts osteoclast formation and blocks the interaction between multiple myeloma cells and osteoclasts.

  7. Drug

    Zafirlukast

    go.drugbank.com/drugs/DB00549
    Approved

    It is available as a tablet and is usually dosed twice daily. Another leukotriene receptor antagonist is montelukast (Singulair), which is usually taken just once daily.

  8. Drug

    Pirfenidone

    go.drugbank.com/drugs/DB04951
    ApprovedInvestigational

    [A251365] The FDA first approved pirfenidone alongside [nintedanib] as one of the first drugs to treat IPF.[A251165]

  9. Drug

    Anatibant

    go.drugbank.com/drugs/DB05038
    Experimental

    Anatibant is a selective, very potent, small-molecule Bradykinin B2 receptor antagonist. It is developed for the for the treatment of traumatic brain injury (TBI).

  10. Drug

    NAV 1800

    go.drugbank.com/drugs/DB05437
    Experimental

    RIGScan CR49, a 125I-labelled CR monoclonal antibody directed against the tumour-associated antigen TAG-72, is undergoing development with Neoprobe for the intraoperative detection of metastatic colorectal cancer.